FDCDDQ
PCRX icon

Federation des caisses Desjardins du Quebec’s Pacira BioSciences PCRX Stock Holding History

Federation des caisses Desjardins du Quebec’s Portfolio PCRX Stock Details PCRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-190
Closed -$4.72K – 2809
2025
Q1 		$4.72K Buy
+190
New +$4.55K ﹤0.01% 2187
2022
Q4 		– Sell
-2
Closed -$106 – 2526
2022
Q3 		$106 Hold
2
– – ﹤0.01% 2466
2022
Q2 		$117 Buy
+2
New +$131 ﹤0.01% 2498

Other funds holding PCRX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
DPCM
Doma Perpetual Capital Management Miami, Florida $372M AUM 14.96% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Federation des caisses Desjardins du Quebec's PCRX Position: Q2 2025 in Review

Federation des caisses Desjardins du Quebec sold out of Pacira BioSciences (PCRX) in Q2 2025, closing a stake of 190 shares — an estimated $4.72K sold.

Federation des caisses Desjardins du Quebec first reported a position in PCRX in Q2 2022 and held it in 3 quarters. The position peaked at $4.72K in Q1 2025. 233 funds tracked by Wall St. Rank hold PCRX as of Q2 2025.

  • Federation des caisses Desjardins du Quebec reported no remaining Pacira BioSciences position as of Q2 2025 after selling out during the quarter.
  • Federation des caisses Desjardins du Quebec sold 190 Pacira BioSciences shares in Q2 2025, an estimated $4.72K.
  • Federation des caisses Desjardins du Quebec first reported a position in Pacira BioSciences in Q2 2022 and held it in 3 quarters.
  • Federation des caisses Desjardins du Quebec's Pacira BioSciences position peaked at $4.72K in Q1 2025.
  • 233 funds tracked by Wall St. Rank held Pacira BioSciences as of Q2 2025.

Based on Federation des caisses Desjardins du Quebec's 13F filing for Q2 2025, filed 14 Aug 2025.